Axa
IRWD icon

Axa’s Ironwood Pharmaceuticals IRWD Stock Holding History

Axa’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-332,810
Closed -$489K – 1152
2025
Q1 		$489K Buy
332,810
+44,339
+15% +$106K ﹤0.01% 929
2024
Q4 		$1.28M Buy
+288,471
New +$1.17M ﹤0.01% 834
2024
Q3 		– Sell
-28,168
Closed -$184K – 1114
2024
Q2 		$184K Sell
28,168
-3,258
-10% -$23K ﹤0.01% 1028
2024
Q1 		$274K Sell
31,426
-75,417
-71% -$915K ﹤0.01% 997
2023
Q4 		$1.22M Buy
106,843
+80,043
+299% +$792K ﹤0.01% 811
2023
Q3 		$258K Sell
26,800
-5,000
-16% -$49K ﹤0.01% 997
2023
Q2 		$338K Buy
31,800
+9,900
+45% +$106K ﹤0.01% 985
2023
Q1 		$230K Buy
+21,900
New +$245K ﹤0.01% 1057
2021
Q4 		– Sell
-77,400
Closed -$1.01M – 1230
2021
Q3 		$1.01M Sell
77,400
-355,500
-82% -$4.59M ﹤0.01% 963
2021
Q2 		$5.57M Buy
+432,900
New +$4.96M 0.02% 678
2016
Q1 		– Sell
-515,115
Closed -$5M – 1365
2015
Q4 		$5M Sell
515,115
-4,433
-0.9% -$42.8K 0.02% 561
2015
Q3 		$4.53M Buy
519,548
+14,146
+3% +$132K 0.02% 599
2015
Q2 		$5.11M Buy
505,402
+5,565
+1% +$64.7K 0.02% 590
2015
Q1 		$6.7M Sell
499,837
-57,621
-10% -$756K 0.03% 502
2014
Q4 		$7.15M Sell
557,458
-299,822
-35% -$3.43M 0.03% 470
2014
Q3 		$9.3M Buy
857,280
+8,432
+1% +$96.5K 0.04% 395
2014
Q2 		$10.9M Sell
848,848
-23,063
-3% -$251K 0.05% 385
2014
Q1 		$9M Buy
871,911
+135,946
+18% +$1.53M 0.04% 406
2013
Q4 		$7.16M Buy
735,965
+25,576
+4% +$230K 0.03% 443
2013
Q3 		$7.05M Buy
710,389
+155,826
+28% +$1.53M 0.03% 441
2013
Q2 		$4.62M Buy
+554,563
New +$6.72M 0.02% 494

Other funds holding IRWD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Axa's IRWD Position: Q2 2025 in Review

Axa sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2025, closing a stake of 332,810 shares — an estimated $489K sold.

Axa first reported a position in IRWD in Q2 2013 and held it in 21 quarters. The position peaked at $10.9M in Q2 2014. 155 funds tracked by Wall St. Rank hold IRWD as of Q2 2025.

  • Axa reported no remaining Ironwood Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Axa sold 332,810 Ironwood Pharmaceuticals shares in Q2 2025, an estimated $489K.
  • Axa first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 21 quarters.
  • Axa's Ironwood Pharmaceuticals position peaked at $10.9M in Q2 2014.
  • 155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2025.

Based on Axa's 13F filing for Q2 2025, filed 14 Aug 2025.